aa
Home
Sitemap
Contact Us
HOME
ABOUT
Aims and Scope
About the KJM
General Information
Editorial Board
Best Pracitce
Open Access
Contact us
BROWSE ARTICLES
All issues
Accepted Articles
Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Korean J Med
Search
Author Index
EDITORIAL POLICY
Research and Publication Ethics
Peer Review Policy
Preprints Policy
Advertising Policy
Data Archiving Policy
Data Sharing Policy
FOR CONTRIBUTORS
Instructions for Authors
Copyright Transfer Agreements
Article-processing Charge
E-Submission
Search
Korean J Med
Search
Page Path
HOME
BROWSE ARTICLES
Search
Infectious disease / Original Article
Extended-Spectrum β-Lactamase 생성 장내세균속균종 균혈증 환자들의 치료에서 비카바페넴 항생제의 단일 기관 치료 결과: Piperacillin-Tazobactam을 중점으로
Hyunjoo Oh, Seunghee Lee, Misun Kim, Sang Taek Heo, Jeong Rae Yoo
Korean J Med.
2024;99(3):149-157.
Published online June 1, 2024
DOI:
https://doi.org/10.3904/kjm.2024.99.3.149
Full text
PubReader
ePub
PDF
감염 / Case Report
간경변 환자에서 발생한 Extended-spectrum Beta-lactamase 생성
Eshcerichia coli
에 의한 지역발생 괴사성 근막염 1예
Ji Hye Jang, Chang Wook Kim, Se Young Kim, Youn Jung Park, Min Ji Seo, Seon A Kim
Korean J Med.
2017;92(4):419-423.
Published online August 1, 2017
DOI:
https://doi.org/10.3904/kjm.2017.92.4.419
Full text
PubReader
ePub
PDF
1
Korean Journal
of Medicine
Print ISSN: 1738-9364
Online ISSN: 2289-0769
MOST VIEWED
MOST CITED
23,906
Review of Antibody-Drug Conjugates
9,623
Diagnosis and Treatment of Premature Atrial or Ventricular Complexes
10,662
Updated Guidelines for Acute Respiratory Distress Syndrome
8,790
Core Elements for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals
13,025
New Guidelines for Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
+more
Cited By
1
Non-face-to-face Treatment in Korea: Suggestions for Essential Conditions
Cited By
1
Interpretation of Estimated Glomerular Filtration Rate
Cited By
1
The First Step in Resolving Medical Disputes Involving Physicians of South Korea: Fair Medical Appraisal
Cited By
1
SGLT2 Inhibitors: Emerging Drugs in Heart Failure
Cited By
1
Non-invasive Evaluation of Liver Fibrosis
+more